Clinical Research

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 61 total displayed.

Most recent content

CCR Focus
Oncologic Phase 0 Trials Incorporating Clinical Pharmacodynamics: from Concept to Patient

James H. Doroshow and Ralph E. Parchment
Clin. Cancer Res. 2008; 14: 3658-3663. [Abstract] [Full text] [PDF]  

CCR Focus
The Development of Phase I Cancer Trial Methodologies: the Use of Pharmacokinetic and Pharmacodynamic End Points Sets the Scene for Phase 0 Cancer Clinical Trials

A. Hilary Calvert and Ruth Plummer
Clin. Cancer Res. 2008; 14: 3664-3669. [Abstract] [Full text] [PDF]  

CCR Focus
Leveraging Exploratory Investigational New Drug Studies to Accelerate Drug Development

David Jacobson-Kram and George Mills
Clin. Cancer Res. 2008; 14: 3670-3674. [Abstract] [Full text] [PDF]  

CCR Focus
Designing Phase 0 Cancer Clinical Trials

Anthony J. Murgo, Shivaani Kummar, Larry Rubinstein, Martin Gutierrez, Jerry Collins, Robert Kinders, Ralph E. Parchment, Jiuping Ji, Seth M. Steinberg, Sherry X. Yang, Melinda Hollingshead, Alice Chen, Lee Helman, Robert Wiltrout, Joseph E. Tomaszewski, and James H. Doroshow
Clin. Cancer Res. 2008; 14: 3675-3682. [Abstract] [Full text] [PDF]  

CCR Focus
Phase 0 Trials: An Industry Perspective

Helen Eliopoulos, Vincent Giranda, Robert Carr, Rita Tiehen, Terri Leahy, and Gary Gordon
Clin. Cancer Res. 2008; 14: 3683-3688. [Abstract] [Full text] [PDF]  

CCR Focus
Patient Perspectives on Phase 0 Clinical Trials

Martin Gutierrez and Deborah Collyar
Clin. Cancer Res. 2008; 14: 3689-3691. [Full text] [PDF]  

CCR Focus
The Ethics of Phase 0 Oncology Trials

Emily Abdoler, Holly Taylor, and David Wendler
Clin. Cancer Res. 2008; 14: 3692-3697. [Abstract] [Full text] [PDF]  

Review
Tissue-Based Research in Kidney Cancer: Current Challenges and Future Directions

Sabina Signoretti, Gennady Bratslavsky, Frederick M. Waldman, Victor E. Reuter, John Haaga, Maria Merino, George V. Thomas, Michael R. Pins, Towia Libermann, John Gillespie, Joseph E. Tomaszewski, Carolyn C. Compton, Andrew Hruszkewycz, W. Marston Linehan, and Michael B. Atkins
Clin. Cancer Res. 2008; 14: 3699-3705. [Abstract] [Full text] [PDF]  

Past content

Subject Reviews
Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective

Chih-Pin Chuu, Rou-Yu Chen, John L. Barkinge, Mark F. Ciaccio, and Richard B. Jones
Mol. Cancer Res. 2008; 6: 885-891. [Abstract] [Full text] [PDF]  

Review
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies

Jorge A. Garcia and David Danielpour
Mol. Cancer Ther. 2008; 7: 1347-1354. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7